title: [Application of the Moving Strip Technique of Fletcher in the radiation treatment of primary malignant tumours of the ovary (author's transl)].
abstract: The moving Strip Technique for irradiation of the abdomen perfected by Fletcher and Delclos represents considerable progress in terms of radiotherapy for carcinomas of the ovary by virtue of its simplicity, good tolerance, the homogeneous dose delivered to the entire abdominal cavity and the absence of sequelae. It is possible to deliver a dose of the order of 2.500 rads in 10 days to each abdominal segment, this being equivalent of 3,500 rads in 3,5 weeks. This moderate dose is aimed only at dealing with micronodular invasion and the superimposition of added local doses is required for residual tumour, marked using clips. Of 18 cases treated, including. 15 et stages III and IV, overall survival at 4 years is 52.5%. Two patients at stage III survived for more than 2 years with radiotherapy alone, whilst all at stages I and II are still alive. Have survived for more than two years with radiotherapy alone, whilst all at stages I and II are still alive. From a histological standpoint, the worst group seems to be adenocarcinomas (all dead). Systematic sequential surgery for excision or reduction, chemotherapy to dry out ascites, moving strip irradiation with superimposed doses locally and long term chemotherapy should make it possible to improve the prognostic results of this tumour, for which the outlook remains poor.
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy; D003536:Cystadenocarcinoma / Q000401:mortality / Q000532:radiotherapy; D003537:Cystadenoma / Q000401:mortality / Q000532:radiotherapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy / Q000379:methods*
vernacular_title: Application de la technique d'irradiation en bandes de l'abdomen (Moving Strip Technique de Fletcher) au traitement des tumeurs malignes primitives de l'ovaire.